Developer docs
API playgroundTry for free, no card

Search company profiles

Intelligent Fingerprinting

Full company profile

uuid0003i2u

Namestring
Intelligent Fingerprinting
Legal namestring
Intelligent Fingerprinting Ltd.
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Intelligent Fingerprinting Ltd., founded in 2007 by Chemistry Professor David Russell at the University of East Anglia, develops and manufactures a non-invasive fingerprint sweat-based drug screening system for workplace safety applications. Its core technology is a lateral flow immunoassay using fluorescence-labelled antibodies that detects drug metabolites in sweat collected from all ten fingertips. The product consists of two components: a single-use, tamper-evident Drug Screening Cartridge and a portable Drug Screening Reader that displays negative or non-negative results within approximately ten minutes, with batch testing capability of six tests in roughly three minutes per test. The detection window is targeted at recent drug use (16-24 hours), explicitly optimized for fitness-for-duty assessments rather than lifestyle monitoring. The company holds ISO 9001:2015 and ISO 13485:2016 certifications and operates confirmatory testing through a UKAS-accredited laboratory partner (LGC) using LC-MS/MS.

The company is a wholly owned subsidiary of Intelligent Bio Solutions Inc. (NASDAQ: INBS) and is headquartered in Cambridge, United Kingdom, with an 11-50 employee base and a network of 18 distribution partners covering 24 countries across the UK, Europe, the Middle East and Africa, Asia Pacific, and the United States. Its revenue model combines one-time hardware sales of the Reader (£2,560 example price) with recurring consumable cartridge sales (£1,280 per 80 tests), supplemented by training services (£600 per session) and back-to-lab confirmation kits (~£312 per 4 non-negative events). Go-to-market is enterprise field sales targeting safety-critical industries — construction, transport and logistics, manufacturing, and mining — augmented by distribution partners including Spjotgard (Scandinavia) and SMARTOX (US forensic market). Named enterprise customers include Transport UK London Bus (4,400+ employees across 14 sites), Smurfit Westrock, A&F Sprinklers, Precision Stevedores, Bouygues Construction (12 UK project sites), and Barcaldine Regional Council (Australia). The company has an FDA 510(k) submission filed in December 2024 with U.S. market entry planned for 2025, and previously raised approximately $23 million in disclosed funding rounds between 2011 and 2020.

Short descriptiontext

Intelligent Fingerprinting develops a non-invasive fingerprint sweat-based drug screening system (single-use cartridge plus portable Reader) that delivers results in under ten minutes for workplace safety testing across construction, transport, manufacturing, and mining in 24 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNorwich, United Kingdom
HQ citystring
Norwich
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
workplace drug testing, fingerprint sweat analysis, lateral flow immunoassay, safety-critical screening, point-of-care diagnostics
Industry3 codes
1Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels)
CodeHLAHAOAGPrimaryYes
2Drug & Alcohol Testing Coordination
CodeBPACALAEPrimaryNo
3Toxicology & Therapeutic Drug Monitoring Laboratories
CodeHLAFAMAFPrimaryNo
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical and Diagnostic Laboratories62151
  • Investigation and Personal Background Check Services561611
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
Product category
Workplace Drug Screening Diagnostics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Drug Screening Hardware
TypeHardware Sales
Description

Sale of the Intelligent Fingerprinting Drug Screening Reader - a one-time capital investment that acts as an impartial official for testing. Includes hard carry case.

intelligentfingerprinting.com
2Drug Screening Consumables
TypeHardware Sales
Description

Sale of single-use Drug Screening Cartridges for each test. Cartridges have a two-year shelf life from date of manufacture.

intelligentfingerprinting.com
3Training Services
TypeProfessional Services
Description

Comprehensive training in application and collection of specimens, with virtual and in-person options available. Training and certification allows nominated personnel to administer sweat drug screening.

intelligentfingerprinting.com
4Laboratory Confirmation Services
TypeProfessional Services
Description

Back-to-lab confirmation service using Fingerprint Collection Kit for Laboratory Analysis. Samples sent to independent UKAS-accredited laboratory for confirmatory analysis using liquid chromatography-mass spectrometry.

intelligentfingerprinting.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Pricing details4 tiers
1Drug Screening Reader
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

One-time investment in Intelligent Fingerprinting Drug Screening Reader. Acts as impartial official. Includes hard carry case. Example cost: £2,560 for Reader purchase.

intelligentfingerprinting.com
2Drug Screening Cartridges
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Single-use Drug Screening Cartridges. Two-year shelf life. Example cost: £1,280 for 80 tests (based on cost comparison analysis).

intelligentfingerprinting.com
3Training Services
ModelOtherBilling cadenceAnnual
Notes

Training cost of £600 for fingerprint method vs £800 for urine/saliva methods, based on UK averages.

intelligentfingerprinting.com
4Back-to-Lab Confirmation Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Back-to-lab kit and laboratory testing approximately £312 for 4 non-negative events.

intelligentfingerprinting.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Intelligent Fingerprinting designs, manufactures, and sells a non-invasive fingerprint sweat-based drug screening system for workplace use. The two-part product consists of single-use Drug Screening Cartridges and a portable Drug Screening Reader that uses fluorescence-labelled antibody lateral flow immunoassay to detect drug metabolites (opiates, methamphetamine, cocaine, THC, etc.) within a 16-24 hour window, delivering on-screen results in approximately 10 minutes. A back-to-lab Fingerprint Collection Kit enables UKAS-accredited LC-MS/MS confirmation when non-negative results require legal defence.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Testing 100% of workforce (160 tests) in under 90 minutes
+5 more records
Product overview1 text field

Intelligent Fingerprinting offers a fingerprint sweat-based drug screening system consisting of two core products: the single-use Drug Screening Cartridge (lateral flow immunoassay with fluorescence detection) and the portable Drug Screening Reader. These work together to collect fingertip sweat samples and deliver negative/non-negative screening results in approximately 10 minutes. An add-on Fingerprint Collection Kit for Laboratory Analysis enables confirmatory testing via liquid chromatography-mass spectrometry at UKAS-accredited laboratories when non-negative results require confirmation. The company also offers Breath Alcohol Testing as a complementary product. The detection window focuses on recent drug use (16-24 hours), supporting fitness-for-duty decisions rather than lifestyle monitoring.

Product and service5 records
1Intelligent Fingerprinting Drug Screening Cartridge
CategoryDrug Screening Consumables
Description

Single-use, tamper-evident cartridge that collects sweat from all ten fingertips using lateral flow immunoassay with fluorescence-labelled antibodies. Detects drug use including opiates, methamphetamine, cocaine, cannabis (THC), and more within a 16-24 hour detection window. Sold as a consumable with a two-year shelf life for workplace drug screening in safety-critical industries.

2Intelligent Fingerprinting Drug Screening Reader
CategoryDrug Screening Hardware
Description

Portable fluorescence measurement instrument that reads the Drug Screening Cartridge and displays negative or non-negative screening results on screen within approximately 10 minutes. Supports batch testing of six individuals concurrently, reducing time per test to about three minutes. Multilingual interface supports English, Arabic, and Latin American Spanish. Sold as a one-time capital purchase (example price £2,560 including hard carry case).

3Fingerprint Collection Kit for Laboratory Analysis
CategoryLaboratory Confirmation Services
Description

End-to-end confirmatory analysis kit used when a non-negative screening result requires laboratory confirmation. Includes tamper-evident collection materials, chain-of-custody documentation, and secure packaging for transport to a UKAS-accredited laboratory partner (LGC) where samples are analysed using liquid chromatography-mass spectrometry (LC-MS/MS) for legally defensible confirmation results.

4Breath Alcohol Testing
CategoryWorkplace Substance Testing
Description

Breath alcohol testing solution offered as a complementary product to the fingerprint drug screening system, providing enterprises with a comprehensive workplace substance testing offering for safety-critical environments.

5Training and Certification Services
CategoryProfessional Training Services
Description

Comprehensive training in the application and collection of fingerprint sweat specimens, available as virtual or in-person options. Certification allows nominated customer personnel to administer sweat drug screening on site, delivered as a paid professional service.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierFlagship Enterprise CustomerTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-01
Description

Global construction leader adopting fingerprint drug testing across UK operations. Employs approximately 35,600 people across more than 50 countries with €10.3 billion in sales in 2024. UK rollout begins with 12 project sites. Partnership marks important step toward safer, more efficient workplace practices in large, complex construction environments.

Strategic tierKey Regional PartnerTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-01-01
Description

Regional distributor for Scandinavia (Sweden, Norway, Denmark) with increasing interest from Finland. Founded in 2021 by team with deep pharmaceutical expertise. Has positioned Intelligent Fingerprinting Drug Testing Solution as its flagship workplace drug testing solution. Expanding reach by partnering with complementary service providers including alcohol testing and drug-detection dog services.

Strategic tierKey Us Market PartnerTypeChannel Partner/ Reseller/ Distributor
Description

US-based provider of drug and alcohol testing products and services founded in 2012. Offers comprehensive portfolio for healthcare, justice, corporate, and education settings. Provides fully integrated services encompassing design, customer service, and administrative support. Distribution partner for US Forensic Use Only market.

Strategic tierCore Service PartnerTypeStrategic or Co-development Partner
Description

UKAS-approved laboratory partner providing confirmatory analysis using liquid chromatography-mass spectrometry. Enables identification and quantification of specific drugs with high degree of accuracy for legally defensible confirmation results.

5Barcaldine Regional Council
Strategic tierKey Customer Case StudyTypeOthers
Description

Remote Queensland local government that completed 160 non-invasive tests in under 90 minutes testing 100% of workforce. Following initial test, council personnel trained to conduct random testing in-house through Company's on-site testing model.

intelligentfingerprinting.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Quest Diagnostics operates one of the largest workplace drug testing laboratory networks in the US. Incumbent employer-services provider whose traditional urine-based lab offering Intelligent Fingerprinting competes against; less specialized but dominant in market share and procurement relationships.

TypeDirect peer
Description

Premier Biotech manufactures oral fluid drug testing devices and services for workplace and criminal justice markets. Direct peer in rapid non-invasive drug screening with comparable POCT cartridge-plus-reader architecture.

TypeBroad incumbent
Description

LabCorp provides workplace drug testing services through its Diagnostics Laboratory segment. Broad incumbent serving similar employer and occupational health customers with established urine, oral fluid, and hair testing workflows that Intelligent Fingerprinting positions as legacy alternatives.

TypeRegional player
Description

Cellmark is a UK-based forensic DNA and toxicology services provider serving criminal justice and coroners. Comparable to Intelligent Fingerprinting's UK forensic and confirmation lab services through LGC, with geographic overlap in UK forensic drug testing market.

TypeEmerging player
Description

Drägerwerk manufactures the DrugCheck saliva-based rapid drug test and breath alcohol devices used in workplace safety. Comparable as a portable non-invasive drug/alcohol screening provider in industrial safety, with partial overlap on Intelligent Fingerprinting's transport and mining verticals.

TypeDirect peer
Description

Securetec develops saliva-based rapid drug detection systems (DrugWipe) used by employers, law enforcement, and roadside testing. Direct peer offering non-invasive POCT drug screening with similar European market presence and workplace safety use cases.

TypeDirect peer
Description

Psychemedics provides hair-based drug testing for workplace and forensic applications. Directly comparable as an alternative-specimen (non-urine) drug testing provider targeting the same employer and criminal justice buyers as Intelligent Fingerprinting, though with longer detection window.

TypeDirect peer
Description

OraSure Technologies manufactures rapid oral fluid-based drug testing devices (Intercept) used in workplace and forensic settings. Directly comparable to Intelligent Fingerprinting as a non-invasive POCT drug-of-abuse testing provider serving similar safety-critical verticals with FDA-cleared products.

TypeBroad incumbent
Description

Abbott (via the Alere acquisition) operates a broad toxicology and POCT diagnostics portfolio including workplace drug testing solutions. Large established player with overlapping capabilities but focused across multiple diagnostic categories rather than specializing in sweat-based workplace testing.

TypeBroad incumbent
Description

Eurofins operates toxicology laboratory services for workplace, forensic, and pharmaceutical drug testing globally. Comparable as a confirmation-testing laboratory partner alternative and as a broad toxicology incumbent whose LC-MS confirmation services compete with Intelligent Fingerprinting's LGC-partnered workflow.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Intelligent Fingerprinting

Workplace Drug Screening Diagnosticsintelligentfingerprinting.com

Intelligent Fingerprinting develops a non-invasive fingerprint sweat-based drug screening system (single-use cartridge plus portable Reader) that delivers results in under ten minutes for workplace safety testing across construction, transport, manufacturing, and mining in 24 countries.

What Intelligent Fingerprinting does

Intelligent Fingerprinting Ltd., founded in 2007 by Chemistry Professor David Russell at the University of East Anglia, develops and manufactures a non-invasive fingerprint sweat-based drug screening system for workplace safety applications. Its core technology is a lateral flow immunoassay using fluorescence-labelled antibodies that detects drug metabolites in sweat collected from all ten fingertips. The product consists of two components: a single-use, tamper-evident Drug Screening Cartridge and a portable Drug Screening Reader that displays negative or non-negative results within approximately ten minutes, with batch testing capability of six tests in roughly three minutes per test. The detection window is targeted at recent drug use (16-24 hours), explicitly optimized for fitness-for-duty assessments rather than lifestyle monitoring. The company holds ISO 9001:2015 and ISO 13485:2016 certifications and operates confirmatory testing through a UKAS-accredited laboratory partner (LGC) using LC-MS/MS.

The company is a wholly owned subsidiary of Intelligent Bio Solutions Inc. (NASDAQ: INBS) and is headquartered in Cambridge, United Kingdom, with an 11-50 employee base and a network of 18 distribution partners covering 24 countries across the UK, Europe, the Middle East and Africa, Asia Pacific, and the United States. Its revenue model combines one-time hardware sales of the Reader (£2,560 example price) with recurring consumable cartridge sales (£1,280 per 80 tests), supplemented by training services (£600 per session) and back-to-lab confirmation kits (~£312 per 4 non-negative events). Go-to-market is enterprise field sales targeting safety-critical industries — construction, transport and logistics, manufacturing, and mining — augmented by distribution partners including Spjotgard (Scandinavia) and SMARTOX (US forensic market). Named enterprise customers include Transport UK London Bus (4,400+ employees across 14 sites), Smurfit Westrock, A&F Sprinklers, Precision Stevedores, Bouygues Construction (12 UK project sites), and Barcaldine Regional Council (Australia). The company has an FDA 510(k) submission filed in December 2024 with U.S. market entry planned for 2025, and previously raised approximately $23 million in disclosed funding rounds between 2011 and 2020.

Intelligent Fingerprinting firmographics

Firmographics
Name
Intelligent Fingerprinting
Legal name
Intelligent Fingerprinting Ltd.
Website
https://intelligentfingerprinting.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
Intelligent Fingerprinting develops a non-invasive fingerprint sweat-based drug screening system (single-use cartridge plus portable Reader) that delivers results in under ten minutes for workplace safety testing across construction, transport, manufacturing, and mining in 24 countries.
Ownership category
akta.pro rank

Intelligent Fingerprinting industry classification

Industry
Product category
Workplace Drug Screening Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151), Investigation and Personal Background Check Services (561611)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
akta.pro primary industry
Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels) (HLAHAOAG)
akta.pro secondary industries
Drug & Alcohol Testing Coordination (BPACALAE), Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

Keywords

  • Workplace drug testing
  • Fingerprint sweat analysis
  • Lateral flow immunoassay
  • Safety-critical screening
  • Point-of-care diagnostics

Where Intelligent Fingerprinting is headquartered

Location

Headquarters

HQ city
Norwich
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Intelligent Fingerprinting business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Drug Screening Hardware: Sale of the Intelligent Fingerprinting Drug Screening Reader - a one-time capital investment that acts as an impartial official for testing. Includes hard carry case.
  2. Drug Screening Consumables: Sale of single-use Drug Screening Cartridges for each test. Cartridges have a two-year shelf life from date of manufacture.
  3. Training Services: Comprehensive training in application and collection of specimens, with virtual and in-person options available. Training and certification allows nominated personnel to administer sweat drug screening.
  4. Laboratory Confirmation Services: Back-to-lab confirmation service using Fingerprint Collection Kit for Laboratory Analysis. Samples sent to independent UKAS-accredited laboratory for confirmatory analysis using liquid chromatography-mass spectrometry.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractDrug Screening Reader
Unit PricingPay-as-you-goDrug Screening Cartridges
OtherAnnualTraining Services
Unit PricingPay-as-you-goBack-to-Lab Confirmation Kit

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Intelligent Fingerprinting product offering

Product offering

Core offering

Intelligent Fingerprinting designs, manufactures, and sells a non-invasive fingerprint sweat-based drug screening system for workplace use. The two-part product consists of single-use Drug Screening Cartridges and a portable Drug Screening Reader that uses fluorescence-labelled antibody lateral flow immunoassay to detect drug metabolites (opiates, methamphetamine, cocaine, THC, etc.) within a 16-24 hour window, delivering on-screen results in approximately 10 minutes. A back-to-lab Fingerprint Collection Kit enables UKAS-accredited LC-MS/MS confirmation when non-negative results require legal defence.

Product overview

Intelligent Fingerprinting offers a fingerprint sweat-based drug screening system consisting of two core products: the single-use Drug Screening Cartridge (lateral flow immunoassay with fluorescence detection) and the portable Drug Screening Reader. These work together to collect fingertip sweat samples and deliver negative/non-negative screening results in approximately 10 minutes. An add-on Fingerprint Collection Kit for Laboratory Analysis enables confirmatory testing via liquid chromatography-mass spectrometry at UKAS-accredited laboratories when non-negative results require confirmation. The company also offers Breath Alcohol Testing as a complementary product. The detection window focuses on recent drug use (16-24 hours), supporting fitness-for-duty decisions rather than lifestyle monitoring.

Differentiator

Problem solved

Functional benefit

Products and services

  • Intelligent Fingerprinting Drug Screening Cartridge Single-use, tamper-evident cartridge that collects sweat from all ten fingertips using lateral flow immunoassay with fluorescence-labelled antibodies. Detects drug use including opiates, methamphetamine, cocaine, cannabis (THC), and more within a 16-24 hour detection window. Sold as a consumable with a two-year shelf life for workplace drug screening in safety-critical industries.
  • Intelligent Fingerprinting Drug Screening Reader Portable fluorescence measurement instrument that reads the Drug Screening Cartridge and displays negative or non-negative screening results on screen within approximately 10 minutes. Supports batch testing of six individuals concurrently, reducing time per test to about three minutes. Multilingual interface supports English, Arabic, and Latin American Spanish. Sold as a one-time capital purchase (example price £2,560 including hard carry case).
  • Fingerprint Collection Kit for Laboratory Analysis End-to-end confirmatory analysis kit used when a non-negative screening result requires laboratory confirmation. Includes tamper-evident collection materials, chain-of-custody documentation, and secure packaging for transport to a UKAS-accredited laboratory partner (LGC) where samples are analysed using liquid chromatography-mass spectrometry (LC-MS/MS) for legally defensible confirmation results.
  • Breath Alcohol Testing Breath alcohol testing solution offered as a complementary product to the fingerprint drug screening system, providing enterprises with a comprehensive workplace substance testing offering for safety-critical environments.
  • Training and Certification Services Comprehensive training in the application and collection of fingerprint sweat specimens, available as virtual or in-person options. Certification allows nominated customer personnel to administer sweat drug screening on site, delivered as a paid professional service.

Quantifiable outcome

  • Testing 100% of workforce (160 tests) in under 90 minutes
  • +5 more outcomes

Companies that use Intelligent Fingerprinting

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles3 records

Intelligent Fingerprinting technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Intelligent Fingerprinting partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered flagship enterprise customer, key regional partner, key us market partner, core service partner and key customer case study.

  • Bouygues Constructionflagship enterprise customerChannel Partner/ Reseller/ Distributor · 1 April 2026Global construction leader adopting fingerprint drug testing across UK operations. Employs approximately 35,600 people across more than 50 countries with €10.3 billion in sales in 2024. UK rollout begins with 12 project sites. Partnership marks important step toward safer, more efficient workplace practices in large, complex construction environments.
  • Spjotgardkey regional partnerChannel Partner/ Reseller/ Distributor · 1 January 2021Regional distributor for Scandinavia (Sweden, Norway, Denmark) with increasing interest from Finland. Founded in 2021 by team with deep pharmaceutical expertise. Has positioned Intelligent Fingerprinting Drug Testing Solution as its flagship workplace drug testing solution. Expanding reach by partnering with complementary service providers including alcohol testing and drug-detection dog services.
  • SMARTOXkey us market partnerChannel Partner/ Reseller/ DistributorUS-based provider of drug and alcohol testing products and services founded in 2012. Offers comprehensive portfolio for healthcare, justice, corporate, and education settings. Provides fully integrated services encompassing design, customer service, and administrative support. Distribution partner for US Forensic Use Only market.
  • LGC (Laboratory)core service partnerStrategic or Co-development PartnerUKAS-approved laboratory partner providing confirmatory analysis using liquid chromatography-mass spectrometry. Enables identification and quantification of specific drugs with high degree of accuracy for legally defensible confirmation results.
  • Barcaldine Regional Councilkey customer case studyOthersRemote Queensland local government that completed 160 non-invasive tests in under 90 minutes testing 100% of workforce. Following initial test, council personnel trained to conduct random testing in-house through Company's on-site testing model.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Intelligent Fingerprinting competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: Quest Diagnostics operates one of the largest workplace drug testing laboratory networks in the US. Incumbent employer-services provider whose traditional urine-based lab offering Intelligent Fingerprinting competes against; less specialized but dominant in market share and procurement relationships.
  • Laboratory Corporation of America (LabCorp): LabCorp provides workplace drug testing services through its Diagnostics Laboratory segment. Broad incumbent serving similar employer and occupational health customers with established urine, oral fluid, and hair testing workflows that Intelligent Fingerprinting positions as legacy alternatives.
  • Abbott Toxicology (Alere): Abbott (via the Alere acquisition) operates a broad toxicology and POCT diagnostics portfolio including workplace drug testing solutions. Large established player with overlapping capabilities but focused across multiple diagnostic categories rather than specializing in sweat-based workplace testing.
  • Eurofins Scientific: Eurofins operates toxicology laboratory services for workplace, forensic, and pharmaceutical drug testing globally. Comparable as a confirmation-testing laboratory partner alternative and as a broad toxicology incumbent whose LC-MS confirmation services compete with Intelligent Fingerprinting's LGC-partnered workflow.

Direct peers

  • Premier Biotech: Premier Biotech manufactures oral fluid drug testing devices and services for workplace and criminal justice markets. Direct peer in rapid non-invasive drug screening with comparable POCT cartridge-plus-reader architecture.
  • Securetec Detektions-Systeme: Securetec develops saliva-based rapid drug detection systems (DrugWipe) used by employers, law enforcement, and roadside testing. Direct peer offering non-invasive POCT drug screening with similar European market presence and workplace safety use cases.
  • Psychemedics Corporation: Psychemedics provides hair-based drug testing for workplace and forensic applications. Directly comparable as an alternative-specimen (non-urine) drug testing provider targeting the same employer and criminal justice buyers as Intelligent Fingerprinting, though with longer detection window.
  • OraSure Technologies: OraSure Technologies manufactures rapid oral fluid-based drug testing devices (Intercept) used in workplace and forensic settings. Directly comparable to Intelligent Fingerprinting as a non-invasive POCT drug-of-abuse testing provider serving similar safety-critical verticals with FDA-cleared products.

Regional players

  • Cellmark Forensic Services: Cellmark is a UK-based forensic DNA and toxicology services provider serving criminal justice and coroners. Comparable to Intelligent Fingerprinting's UK forensic and confirmation lab services through LGC, with geographic overlap in UK forensic drug testing market.

Emerging players

  • Drägerwerk: Drägerwerk manufactures the DrugCheck saliva-based rapid drug test and breath alcohol devices used in workplace safety. Comparable as a portable non-invasive drug/alcohol screening provider in industrial safety, with partial overlap on Intelligent Fingerprinting's transport and mining verticals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Intelligent Fingerprinting social profiles

Digital presence

Intelligent Fingerprinting compliance and trust

Trust signal

Compliance4 records

Intelligent Fingerprinting financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Intelligent Fingerprinting leadership team

Management profile

Number of profiles

Profiles2 records

Intelligent Fingerprinting funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Intelligent Fingerprinting M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intelligent Fingerprinting

What does Intelligent Fingerprinting do?

Intelligent Fingerprinting designs, manufactures, and sells a non-invasive fingerprint sweat-based drug screening system for workplace use. The two-part product consists of single-use Drug Screening Cartridges and a portable Drug Screening Reader that uses fluorescence-labelled antibody lateral flow immunoassay to detect drug metabolites (opiates, methamphetamine, cocaine, THC, etc.) within a 16-24 hour window, delivering on-screen results in approximately 10 minutes. A back-to-lab Fingerprint Collection Kit enables UKAS-accredited LC-MS/MS confirmation when non-negative results require legal defence.

Is Intelligent Fingerprinting a public or private company?

Intelligent Fingerprinting is a private company. It is classified as corporate owned and is currently operating.

When was Intelligent Fingerprinting founded?

Intelligent Fingerprinting was founded in 2007. It employs 11 to 50 people.

Where is Intelligent Fingerprinting based?

Intelligent Fingerprinting is headquartered in Norwich, United Kingdom, in the Europe region.

How does Intelligent Fingerprinting make money?

Four revenue lines are on record. Drug Screening Hardware is the primary driver. The others are drug Screening Consumables, training Services and laboratory Confirmation Services.

Who are Intelligent Fingerprinting's main competitors?

Broad incumbents on record are Quest Diagnostics, Laboratory Corporation of America (LabCorp), Abbott Toxicology (Alere) and Eurofins Scientific. Direct peers are Premier Biotech, Securetec Detektions-Systeme, Psychemedics Corporation and OraSure Technologies. Cellmark Forensic Services is listed as a regional player. Drägerwerk is listed as an emerging player.

Does Intelligent Fingerprinting have an API?

No public API is recorded for Intelligent Fingerprinting.

What industry is Intelligent Fingerprinting in?

Intelligent Fingerprinting's product category is Workplace Drug Screening Diagnostics. Its primary akta.pro industry code is HLAHAOAG, Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels), with a secondary code of BPACALAE, Drug & Alcohol Testing Coordination. Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals